查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861619

手術縫合市場按產品類型、最終用戶、應用、適應症和傷口類型分類 - 全球預測 2025-2032

Surgical Incision Closures Market by Product Type, End User, Application, Indication, Wound Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，手術縫合市場將成長至 288.5 億美元，複合年成長率為 7.04%。

關鍵市場統計數據
基準年 2024 167.4億美元
預計年份：2025年 179.4億美元
預測年份 2032 288.5億美元
複合年成長率 (%) 7.04%

本文簡要概述了現代傷口縫合的臨床、操作和商業性方面，重點介紹了各醫療保健相關人員的策略重點。

手術縫合仍然是手術全期護理的基礎要素，它影響所有醫療機構的臨床療效、患者復健時間和手術效率。材料科學、器材工程和微創技術的進步改變了外科醫生和護理團隊選擇縫合方案的方式，而不斷變化的醫保報銷機制和醫院採購重點也在持續影響著縫合方案的採用模式。因此，相關人員需要全面觀點臨床療效、營運影響和採購實際情況，才能做出明智的選擇。

材料技術、器械人體工學和門診手術趨勢的創新融合，正在重新定義臨床對縫合解決方案的偏好和採購標準。

由於技術創新、外科手術技術的發展趨勢以及政策的轉變，手術縫合領域正在迅速變化。生物材料（例如可吸收止血基質和生物可吸收縫合線聚合物）的重大進步，顯著改善了其操作性和性能，從而縮短了手術時間並創傷治療。同樣，電動縫合器和一次性輸送系統的符合人體工學的改進，簡化了器械在微創手術流程中的應用，並確保了不同經驗水平的外科醫生都能獲得一致的手術效果。

評估關稅主導的供應鏈調整和採購應對措施，以重塑閉合裝置的採購、製造在地化和商業合約實務。

主要貿易夥伴修訂關稅政策的實施，為醫療設備製造商、經銷商和醫療保健採購商帶來了新的成本動態變化。關稅措施影響了成品和關鍵原料的到岸成本，迫使製造商重新評估其供應鏈佈局和籌資策略。為此，一些供應商正在加快替代供應商的資格認證，將部分生產業務遷至更靠近終端市場的地方，或與通路合作夥伴重新協商商業條款，以維持利潤率和競爭力。

詳細的細分結構將產品類型、臨床應用場景、臨床適應症和傷口分類聯繫起來，以驅動產品開發、證據生成和上市優先排序。

了解產品和終端用戶細分對於將創新與臨床需求和商業性機會相結合至關重要。產品細分包括止血劑、縫合釘、縫線和組織黏合劑。止血劑包括可吸收明膠海綿、氧化再生纖維素和凝血酶製劑，每種止血劑的操作特性和止血效果各不相同，這會影響外科專科的選擇。縫合釘有手動和電動兩種類型，由於其穩定性和速度優勢，電動縫合釘越來越受到複雜和微創手術的青睞。縫合線分為可吸收縫合線和不可吸收縫合線。可吸收材料，例如Poliglecaprone、氧環己酮聚合體和聚乙醇酸，因其可預測的吸收特性和抗張強度而被選用。同時，不可吸收材料，例如尼龍、聚丙烯和絲，仍適用於特定組織類型和需要長期抗張強度的情況。組織黏合劑分為氰基丙烯酸酯黏合劑、纖維蛋白膠和聚乙二醇密封劑，每種黏合劑都適用於特定的傷口環境和臨床路徑。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢對比，導致了閉合技術的採用、監管策略和商業模式的差異。

區域趨勢對技術採納路徑、報銷環境和供應鏈結構有顯著影響。在美洲，醫療保健系統採用公私混合採購模式，因此，能夠縮短住院時間和提高手術效率的價值提案更容易被支付方和大型醫院系統接受。手術自動化和門診擴張方面的轉型投資正在推動對支援當日出院通訊協定的易用型封閉系統的需求。

競爭動態和企業策略表明，產品創新、夥伴關係和供應鏈韌性如何在閉合裝置市場創造獨特的優勢。

傷口縫合領域的競爭趨勢反映了漸進式產品改進與顛覆性材料創新之間的平衡。現有醫療設備製造商持續投資於迭代改進，例如改良縫合線塗層、新一代止血基質和符合人體工學的縫合釘固定裝置。同時，新興參與企業則專注於新型黏合劑、生物活性密封劑和整合式輸送系統，以減少手術室操作步驟。這種產品創新方向，在可靠的真實世界數據和針對性培訓計畫的支持下，影響著臨床選擇，並創造了差異化競爭的機會。

製造商和醫療保健提供者可以採取切實可行的策略步驟，以加強證據產生、實現採購多元化，並使定價與醫療保健總成本保持一致。

產業領導者應採取多管齊下的方法，整合臨床證據、營運價值和供應鏈韌性。首先，應優先投資於針對特定專科終點和使用者體驗變數的臨床試驗和真實世界證據。這將有助於降低產品推廣門檻，同時加強處方集申報和臨床醫生的認可。同時，應開發滿足不同場所（例如門診中心、醫院手術室、診所和居家醫療機構）獨特需求的產品組合和差異化SKU，以簡化採購和使用決策。

一個透明的混合方法研究框架，結合臨床訪談、二手證據綜合和檢驗，旨在為閉合裝置產生可靠的策略性見解。

本分析綜合了結構化混合方法研究途徑結合了初步訪談、文獻綜述和嚴格的三角驗證，以確保研究結果的可靠性和相關性。初步研究包括與各專科的臨床負責人、醫院系統和門診中心的供應鏈主管以及提供營運背景的監管和報銷專家進行深入討論。文獻綜述則利用同儕審查的臨床文獻、監管文件和公共政策文件來檢驗技術主張並分析其應用趨勢。

總之，這項綜合分析強調了臨床證據、程序人體工學和供應鏈適應性之間的相互作用，以決定長期實施的成功。

外科性創傷縫合技術涉及臨床療效、手術效率和供應鏈複雜性三個面向。生物材料和器械設計的創新正在改善外科醫生的操作體驗和患者預後，但商業性成功取決於能否將這些進步與切合實際的採購優先事項和穩健的生產策略相結合。整合可靠的臨床證據、靈活的採購策略和臨床醫生參與的相關人員，將更有能力最大限度地發揮新型縫合技術的價值。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 擴大抗菌縫合線塗層的應用，以降低術後感染率
  • 將智慧傷口監測裝置整合到縫合線中，以獲取即時癒合數據
  • 在微創手術中，對能夠實現無結紮組織縫合的倒刺縫合線的需求日益成長。
  • 透過開發基於可生物分解聚合物的閉合技術，改善患者的創傷治療效果。
  • 拓展機器人縫合技術，以提高複雜手術的精準度

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 按產品類型手術縫合市場

  • 止血材料
    • 吸水明膠海綿
    • 氧化再生纖維素
    • 基於凝血酶
  • 史泰博
    • 手動輸入
    • 電的
  • 縫合線
    • 吸收性
      • Poliglecaprone
      • 氧環己酮聚合體
      • 聚乙醇酸
    • 不可吸收
      • 尼龍
      • 聚丙烯
      • 絲綢
  • 組織黏合劑
    • 氰基丙烯酸黏合劑
    • 纖維蛋白膠
    • 聚乙二醇密封劑

第9章 按最終使用者分類的手術縫合市場

  • 門診手術中心
  • 診所
    • 多專科醫療機構
    • 單一專科
  • 居家醫療
  • 醫院
    • 私人的
    • 民眾

第10章手術縫合市場：依應用領域分類

  • 外部的
  • 內部的

第11章 依適應症分類的手術縫合市場

  • 心血管系統
  • 一般外科
  • 婦科
  • 神經外科
  • 整形外科
  • 兒童外科

第12章 按傷口類型分類的手術縫合市場

  • 清潔傷口
  • 半清潔傷口
  • 受污染的傷口
  • 化膿性傷口

第13章手術縫合市場：依地區分類

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章手術縫合市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國手術縫合市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Johnson & Johnson
    • Medtronic plc
    • 3M Company
    • B. Braun Melsungen AG
    • Smith & Nephew plc
    • Baxter International Inc.
    • Teleflex Incorporated
    • Integra LifeSciences Holdings Corporation
    • Coloplast A/S
    • Terumo Corporation
Product Code: MRR-69324464D312

The Surgical Incision Closures Market is projected to grow by USD 28.85 billion at a CAGR of 7.04% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 16.74 billion
Estimated Year [2025] USD 17.94 billion
Forecast Year [2032] USD 28.85 billion
CAGR (%) 7.04%

A concise orientation to the clinical, operational, and commercial dimensions of modern incision closure that frames strategic priorities for varied healthcare stakeholders

Surgical incision closure remains a foundational element of perioperative care, affecting clinical outcomes, patient recovery times, and procedural efficiency across care settings. Advances in materials science, device engineering, and minimally invasive techniques have changed how surgeons and care teams select closure solutions, while evolving reimbursement frameworks and hospital procurement priorities continue to shape adoption patterns. As a result, stakeholders require an integrated view that combines clinical performance, operational impact, and procurement realities to make informed choices.

This executive summary synthesizes the latest evidence and strategic considerations relevant to clinicians, supply chain leaders, and investors. It emphasizes the interplay between product innovation and system-level pressures, addressing how closure technologies contribute to infection prevention, hemostasis control, and suture line integrity in diverse surgical populations. Moreover, it highlights the importance of aligning device selection with workflow constraints in ambulatory surgical centers, hospitals, clinics, and home care environments, where device ease of use and compatibility with existing protocols drive purchasing decisions.

Moving from clinical to commercial perspectives, the introduction frames the competitive dynamics among hemostats, staples, sutures, and tissue adhesives, and it underscores the regulatory and quality assurance pressures that influence product development cycles. The goal is to present a balanced, actionable orientation that prepares readers to interpret subsequent sections on market shifts, tariff implications, segmentation insights, and recommended strategic responses.

How converging innovations in materials, device ergonomics, and outpatient procedural trends are redefining clinical preferences and procurement criteria in closure solutions

The landscape for surgical incision closure has undergone rapid transformation driven by technology, procedural trends, and policy shifts. Key advances in biomaterials, such as absorbable hemostatic matrices and bioresorbable suture polymers, now offer improved handling and performance characteristics that reduce procedure time and enhance wound healing. Similarly, ergonomic improvements in powered stapling and single-use delivery systems have simplified device integration into minimally invasive workflows, thereby enabling more consistent outcomes across surgeon experience levels.

Concurrently, clinical pathways are shifting toward outpatient and ambulatory care, which increases demand for closure solutions that prioritize rapid application, robust hemostasis, and minimal follow-up. This trend has encouraged manufacturers to design products that combine clinical efficacy with operational simplicity, ensuring that devices meet both clinical and throughput objectives. In parallel, regulatory scrutiny and an emphasis on real-world evidence have elevated the need for robust post-market surveillance and comparative clinical data, prompting suppliers to invest in registries and prospective studies.

Taken together, these shifts are reshaping procurement criteria: value is now measured not only by unit price but also by total cost of care impacts, including infection reduction, readmission avoidance, and OR efficiency gains. As a result, successful market entrants demonstrate differentiated clinical benefits, seamless integration into clinical workflows, and credible evidence packages that resonate with both clinicians and hospital administrators.

Assessment of tariff-driven supply chain adjustments and procurement responses that are reshaping sourcing, manufacturing localization, and commercial contracting practices for closure devices

The introduction of revised tariff policies by major trade partners has introduced new cost dynamics that affect device manufacturers, distributors, and healthcare purchasers. Tariff actions influence the landed cost of both finished goods and critical raw materials, creating pressure on manufacturers to reassess supply chain footprints and sourcing strategies. In response, some suppliers have accelerated efforts to qualify alternate suppliers, relocated certain manufacturing steps closer to end markets, or restructured commercial terms with channel partners to preserve margin and competitiveness.

From a hospital and clinic perspective, procurement teams are increasingly focused on cost transparency and contract flexibility. Transitional measures, such as inventory hedging and negotiated price escalators tied to input cost indices, have become more common. At the same time, clinicians remain sensitive to device performance and safety implications of material substitutions, which requires careful validation and communication from suppliers. Consequently, manufacturers that combine supply chain resilience with demonstrable clinical continuity achieve stronger commercial outcomes.

Importantly, tariff pressures have also accelerated conversations around nearshoring and the diversification of supplier bases. This strategic pivot reduces exposure to single-country risks but introduces complexity in regulatory conformity and quality assurance. Therefore, companies with robust global quality systems and adaptable manufacturing processes are better positioned to manage tariff-driven disruptions while maintaining product innovation and clinical support.

In-depth segmentation architecture linking product modalities, care settings, clinical indications, and wound classifications to inform product development, evidence generation, and go-to-market prioritization

Understanding product and end-user segmentation is essential to aligning innovation with clinical need and commercial opportunity. Product divisions encompass hemostats, staples, sutures, and tissue adhesives, where hemostats include absorbable gelatin sponges, oxidized regenerated cellulose, and thrombin-based formulations, each offering distinct handling characteristics and hemostatic profiles that influence selection by surgical specialty. Staples are offered in manual and powered variants, with powered systems increasingly favored in complex and minimally invasive procedures for their consistency and speed. Sutures divide into absorbable and non-absorbable categories; absorbable materials such as poliglecaprone, polydioxanone, and polyglycolic acid are chosen for their predictable resorption and tensile properties, while non-absorbable options like nylon, polypropylene, and silk remain relevant for specific tissue types and long-term tensile requirements. Tissue adhesives span cyanoacrylate adhesives, fibrin sealants, and polyethylene glycol-based sealants, each suited to particular wound environments and clinical adoption pathways.

End-user segmentation differentiates care settings that impose distinct operational constraints and purchasing behaviors. Ambulatory surgical centers emphasize rapid turnover and cost containment, clinics-both multi-specialty and single-specialty-prioritize ease of use and inventory simplicity, home care demands low-burden application and safety for non-clinical caregivers, and hospitals-public and private-balance clinical efficacy with procurement cycles and contract performance criteria. Applications are classified as external or internal, with internal applications often requiring higher regulatory scrutiny and supporting evidence due to implantation and absorptive behavior.

Clinical indications and wound types further refine product fit: cardiovascular, general surgery, gynecology, neurosurgery, orthopedic, and pediatric indications each present unique tissue handling and hemostasis needs, while wound classifications such as clean, clean contaminated, contaminated, and dirty shape infection control expectations and device selection. Integrating these segmentation layers enables suppliers to prioritize R&D, tailor messaging to procurement stakeholders, and design clinical studies that address specialty-specific endpoints and real-world usability considerations.

Comparative regional dynamics across the Americas, Europe Middle East & Africa, and Asia-Pacific that drive differentiated adoption, regulatory strategies, and commercial models for closure technologies

Regional dynamics exert a strong influence on technology adoption paths, reimbursement environments, and supply chain configurations. In the Americas, healthcare systems present a mix of private and public procurement models, where value propositions that demonstrate reduced length of stay and improved procedural throughput often resonate with payers and large hospital systems. Transitional investments in surgical automation and outpatient expansion drive demand for user-friendly closure systems that support same-day discharge protocols.

In Europe, the Middle East & Africa, regulatory harmonization efforts and varying reimbursement models create a mosaic of adoption criteria. Centralized procurement in some European markets favors standardized product portfolios, while emerging markets within the region prioritize affordability and ease of training. Meanwhile, the Middle East and Africa exhibit pockets of rapid adoption for advanced technologies in tertiary centers, balanced by significant variability in supply chain maturity and access to specialized training.

Asia-Pacific demonstrates heterogeneity across mature markets with high rates of minimally invasive surgery and rapidly growing surgical volumes in developing economies. Manufacturers succeed in this region when they combine localized clinical education programs with adaptable pricing strategies and supply chain flexibility. Across regions, stakeholders that can localize regulatory submissions, invest in clinician training, and adapt commercial models to payer structures gain competitive advantage.

Competitive dynamics and corporate strategies demonstrating how product innovation, partnerships, and supply chain resilience create distinct advantages in closure device markets

Competitive dynamics in the incision closure space reflect a balance between incremental product refinement and disruptive material innovation. Established device manufacturers continue to invest in iterative improvements-such as enhanced suture coatings, next-generation hemostatic matrices, and ergonomic stapling mechanisms-while emerging entrants focus on novel adhesives, bioactive sealants, and integrated delivery systems that reduce steps in the operating room. These product innovation trajectories affect clinical preference and create differentiation opportunities when supported by robust real-world data and targeted training programs.

Strategic collaborations and selective acquisitions have become important pathways for companies to expand their clinical portfolios and accelerate time to market. Partnerships with academic centers and surgical networks enable faster evidence generation and early clinician advocacy, which in turn influence hospital formulary decisions. Moreover, companies that invest in digital support tools-such as procedural guidance platforms and post-market outcome tracking-strengthen customer relationships by demonstrating commitment to long-term clinical performance.

Supply chain resilience, regulatory compliance, and the ability to navigate tariff environments also distinguish leading companies. Firms that maintain diversified manufacturing footprints, transparent quality systems, and agile commercial strategies are better positioned to respond to procurement pressures and clinician expectations. Ultimately, competitive advantage accrues to organizations that align material science innovation with pragmatic clinical support and clear evidence of procedural benefit.

Practical and implementable strategic steps for manufacturers and healthcare providers to strengthen evidence generation, diversify sourcing, and align pricing with total cost of care imperatives

Industry leaders should adopt a multi-faceted approach that aligns clinical evidence, operational value, and supply chain resilience. First, prioritize investment in targeted clinical studies and real-world evidence that address specialty-specific endpoints and user experience variables; this will strengthen formulary submissions and clinician advocacy while reducing adoption friction. In parallel, develop product bundles or differentiated SKUs that match the unique needs of ambulatory centers, hospital ORs, clinics, and home care environments to simplify procurement and usage decisions.

Second, implement supply chain diversification strategies to mitigate tariff and geopolitical exposure. This includes qualifying alternate material suppliers, exploring regional manufacturing partnerships, and refining logistics agreements to ensure consistent product availability. Third, enhance commercial engagement through clinician education programs and digital tools that support procedural adoption and outcomes tracking, thereby building long-term relationships grounded in demonstrable clinical value.

Finally, align pricing and contracting strategies with total cost of care arguments, emphasizing reductions in infection rates, readmissions, and OR time. By presenting clear models that translate clinical performance into operational savings, manufacturers can secure preferred positioning during competitive procurement cycles. These combined actions will help organizations navigate current market pressures while creating durable pathways for growth.

Transparent mixed-method research framework combining clinical interviews, secondary evidence synthesis, and triangulated validation to produce reliable strategic insights for closure devices

This analysis synthesizes insights drawn from a structured, mixed-method research approach combining primary interviews, secondary literature review, and rigorous triangulation to ensure credibility and relevance. Primary research included in-depth discussions with clinical leaders across a range of specialties, supply chain executives from hospital systems and ambulatory centers, and regulatory and reimbursement experts who provided operational context. Secondary analysis drew on peer-reviewed clinical literature, regulatory filings, and publicly available policy documents to validate technical claims and to map adoption trends.

Data synthesis employed cross-validation methods to reconcile differing viewpoints and reduce bias. Clinical inputs were weighted against documented outcomes and device performance data, while procurement and supply chain observations were calibrated with documented policy changes and trade developments. Quality controls included expert peer review and methodological audits to ensure that conclusions rest on confirmed evidence and transparent assumptions. Limitations are acknowledged where gaps in public data exist, and recommendations emphasize adaptive strategies that can be refined as new evidence emerges.

Concluding synthesis emphasizing the critical interplay of clinical evidence, procedural ergonomics, and supply chain adaptability that determines long-term adoption success

Surgical incision closure sits at the intersection of clinical performance, procedural efficiency, and supply chain complexity. Innovations in biomaterials and device design are improving surgeon experience and patient outcomes, yet commercial success depends on aligning those advancements with pragmatic procurement priorities and resilient manufacturing strategies. Stakeholders who integrate robust clinical evidence with adaptive sourcing and clinician engagement will be best positioned to capture the value generated by new closure technologies.

As regulatory scrutiny intensifies and healthcare delivery models continue to evolve toward outpatient care, the ability to demonstrate real-world benefits and operational impact becomes critical. Companies that invest in targeted clinical programs, localized commercialization efforts, and diversified supply chains will reduce adoption friction and preserve margin integrity. Conversely, those that rely solely on unit cost competition without substantiating clinical value may face increasing procurement headwinds.

In conclusion, a disciplined focus on evidence, ergonomics, and supply chain adaptability offers the most reliable route to sustained adoption and commercial differentiation in the evolving world of surgical incision closure.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising adoption of antimicrobial suture coatings to reduce postoperative infection rates
  • 5.2. Integration of smart wound monitoring devices with suture lines for real-time healing data
  • 5.3. Growth in demand for barbed sutures enabling knotless tissue approximation in minimally invasive surgeries
  • 5.4. Advancements in biodegradable polymer-based closures for improved patient wound healing outcomes
  • 5.5. Expansion of robotic-assisted suture placement techniques increasing precision in complex procedures

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Incision Closures Market, by Product Type

  • 8.1. Hemostats
    • 8.1.1. Absorbable Gelatin Sponges
    • 8.1.2. Oxidized Regenerated Cellulose
    • 8.1.3. Thrombin Based
  • 8.2. Staples
    • 8.2.1. Manual
    • 8.2.2. Powered
  • 8.3. Sutures
    • 8.3.1. Absorbable
      • 8.3.1.1. Poliglecaprone
      • 8.3.1.2. Polydioxanone
      • 8.3.1.3. Polyglycolic Acid
    • 8.3.2. Non Absorbable
      • 8.3.2.1. Nylon
      • 8.3.2.2. Polypropylene
      • 8.3.2.3. Silk
  • 8.4. Tissue Adhesives
    • 8.4.1. Cyanoacrylate Adhesives
    • 8.4.2. Fibrin Sealants
    • 8.4.3. Polyethylene Glycol Sealants

9. Surgical Incision Closures Market, by End User

  • 9.1. Ambulatory Surgical Centers
  • 9.2. Clinics
    • 9.2.1. Multi Specialty
    • 9.2.2. Single Specialty
  • 9.3. Home Care
  • 9.4. Hospitals
    • 9.4.1. Private
    • 9.4.2. Public

10. Surgical Incision Closures Market, by Application

  • 10.1. External
  • 10.2. Internal

11. Surgical Incision Closures Market, by Indication

  • 11.1. Cardiovascular
  • 11.2. General Surgery
  • 11.3. Gynecology
  • 11.4. Neurosurgery
  • 11.5. Orthopedic
  • 11.6. Pediatric

12. Surgical Incision Closures Market, by Wound Type

  • 12.1. Clean
  • 12.2. Clean Contaminated
  • 12.3. Contaminated
  • 12.4. Dirty

13. Surgical Incision Closures Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Surgical Incision Closures Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Surgical Incision Closures Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Johnson & Johnson
    • 16.3.2. Medtronic plc
    • 16.3.3. 3M Company
    • 16.3.4. B. Braun Melsungen AG
    • 16.3.5. Smith & Nephew plc
    • 16.3.6. Baxter International Inc.
    • 16.3.7. Teleflex Incorporated
    • 16.3.8. Integra LifeSciences Holdings Corporation
    • 16.3.9. Coloplast A/S
    • 16.3.10. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. SURGICAL INCISION CLOSURES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. SURGICAL INCISION CLOSURES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL INCISION CLOSURES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE GELATIN SPONGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY OXIDIZED REGENERATED CELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY THROMBIN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MANUAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POWERED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLIGLECAPRONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYDIOXANONE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYGLYCOLIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NYLON, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYPROPYLENE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SILK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CYANOACRYLATE ADHESIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY FIBRIN SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY POLYETHYLENE GLYCOL SEALANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY MULTI SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY SINGLE SPECIALTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PRIVATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PUBLIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY EXTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INTERNAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY GYNECOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY ORTHOPEDIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CLEAN CONTAMINATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY CONTAMINATED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY DIRTY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL INCISION CLOSURES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 274. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 275. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 276. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 277. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 278. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2025-2032 (USD MILLION)
  • TABLE 279. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2018-2024 (USD MILLION)
  • TABLE 280. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY STAPLES, 2025-2032 (USD MILLION)
  • TABLE 281. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2018-2024 (USD MILLION)
  • TABLE 282. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY SUTURES, 2025-2032 (USD MILLION)
  • TABLE 283. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 284. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 285. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2018-2024 (USD MILLION)
  • TABLE 286. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY NON ABSORBABLE, 2025-2032 (USD MILLION)
  • TABLE 287. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2018-2024 (USD MILLION)
  • TABLE 288. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY TISSUE ADHESIVES, 2025-2032 (USD MILLION)
  • TABLE 289. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 290. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 291. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
  • TABLE 292. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY CLINICS, 2025-2032 (USD MILLION)
  • TABLE 293. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
  • TABLE 294. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY HOSPITALS, 2025-2032 (USD MILLION)
  • TABLE 295. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 296. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 297. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
  • TABLE 298. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY INDICATION, 2025-2032 (USD MILLION)
  • TABLE 299. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2018-2024 (USD MILLION)
  • TABLE 300. AMERICAS SURGICAL INCISION CLOSURES MARKET SIZE, BY WOUND TYPE, 2025-2032 (USD MILLION)
  • TABLE 301. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 304. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 305. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY HEMOSTATS, 2018-2024 (USD MILLION)
  • TABLE 306. NORTH AMERICA SURGICAL INCISION CLOSURES MARKET SIZE, BY